Results 141 to 150 of about 3,032 (163)

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul Parikh
exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Victoria Metaxa, Elie Azoulay   +2 more
exaly  

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Circadian phenotype of double mutant PAC1/VPAC2 receptor knockout mice

Regulatory Peptides, 2012
J. Hannibal, J. Fahrenkrug
openaire   +1 more source

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Elizabeth A Mittendorf, Hope S Rugo, Gabriel N Hortobagyi   +2 more
exaly  

Targeting receptor complexes: a new dimension in drug discovery

Nature Reviews Drug Discovery, 2020
Mette Ishøy Rosenbaum, Louise Albertsen, David S Bredt   +2 more
exaly  

Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes

Nature Reviews Drug Discovery, 2011
Uwe Rudolph
exaly